Invention Grant
- Patent Title: Formulation for L-tryptophane comprising carbidopa/benserazide
- Patent Title (中): 包含卡比多巴/苄沙星的L-色氨酸的制剂
-
Application No.: US11573633Application Date: 2005-08-12
-
Publication No.: US08642639B2Publication Date: 2014-02-04
- Inventor: Joachim Kamprad
- Applicant: Joachim Kamprad
- Applicant Address: DE Munster
- Assignee: Kamprad KG
- Current Assignee: Kamprad KG
- Current Assignee Address: DE Munster
- Agency: Cesari and McKenna, LLP
- Priority: DE102004039196 20040812
- International Application: PCT/DE2005/001428 WO 20050812
- International Announcement: WO2006/015590 WO 20060216
- Main IPC: A01N43/38
- IPC: A01N43/38 ; A61K31/40 ; C07D209/20
Abstract:
The present invention relates to the use of L-tryptophan and a peripheral degradation inhibitor of L-tryptophan for the manufacture of a medicament for prevention or therapy of pain, depressions, sleeping disorders and other serotonin dependent diseases of the CNS, wherein L-tryptophan is present in a retarded and the peripheral degradation inhibitor is present in a non-retarded formulation.
Public/Granted literature
- US20110288145A1 Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide Public/Granted day:2011-11-24
Information query
IPC分类:
